Sir, as you mentioned a lot on AI, my question was one of our competitor, Tiger Analytics, they are targeting 1 billion revenue by 2030 as AI will become their core business. So what is our thought process on it? Where are we seeing ourselves like 5 to 6 years down the road?
Questions across 8 calls
Rushabh Shah
Buglerock PMS
Latent View Analytics Limited
So one question for LatentView, hiring is the most important part. So what quality do we investigate in the candidate? And what are your basis of criteria to judge a hired candidate?
So just a second question on the client engagement. So, we do projects for some clients like for some small projects, and we don't have follow -up work with them, in the sense we don't get a long -term contract. So how has LatentView had follow-up with them? And has client s engaged with us after a small project being done for them?
So, in one of the calls, you said that you are doubling down your investments in the CPG, Consumer Retail, and even today, you are saying that the growth in FY25 would be led by CPG, Consumer Retail. So, why do you think so? Sir, what could be the next trigger point for LatentView in coming years in the CPG , Consumer Retail segment?
My second question is, sir, how big will be the data and analytics market? So, the estimates for ‘24 was around $300 billion. Do you think that it will be achieved in this calendar year? And what's your aim for the next 5 years? Where will this market be ? And what will be our market share in this entire universe?
Amara Raja Energy & Mobility Limited
I just wanted to know how will your cash flow plan out in the next couple of years? And like what will be the payback period of the new -- of the capex in the new business?
Sir, my next question is in terms of gross margins as compared your competitor is bit better than us. So just wanted to know the reasons why is it better than -- is it because of the raw material procurement or the lead acid -- lead recycling? Just wanted your thoughts on that?
Indian Energy Exchange Limited
Sir, my question is, in one of the calls, you mentioned that even if coupling happens, we will be able to defend it and defend the market share. Could you please explain in detail how would you do that? What measure will you take to defend your share?
In one of the calls, you mentioned that even if coupling happens, you will be able to defend your market share. So can you explain in detail?
Sir how would you attract new customers so that more and more trading possible on our platform?
And sir, my next question is the open access volumes have only been contributed by a few states. So what necessary actions are we taking so that those volumes increase and all States are participating in these volumes?
Concord Biotech Limited
Yes, I just wanted to ask what is the USP of the Concord Biotech for immunosuppressants APIs, and we are one of the few Indian manufacturers. So, what is different we are doing that other players are not able to do?
Okay. So, sir, as you said , we don't see many companies having that kind of fully integrated approach in some of the niche anti -infectives also so which are for the fermentation so what would be the reason why other companies are not able to do it? Is it because you are in this business for 2 decades? Or what is it, sir?
Caplin Point Laboratories Limited
So, when entering the U.S. market, you would like to cater to smaller players and not competing with the big ones. So, what would be the opportunity size and the target market share?
So just a follow-up on that one. So why is that there are underserved hospitals in U.S.? Why any of the companies have not catered to NEM when they know there is no competition in that segment of the market?